Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic

E B Keeffe1, G M Dusheiko, M J Tong

  • 1Stanford University Medical Center, Palo Alto, CA 94304-1509, USA. ekeeffe@stanford.edu

Cytokines, Cellular & Molecular Therapy
|June 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subglottic cysts: The Great Ormond Street experience in 105 patients.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2020
Same author

Analysis of intensive care admissions among paediatric obstructive sleep apnoea referrals.

Annals of the Royal College of Surgeons of England·2017
Same author

Safe balloon sizing for endoscopic dilatation of subglottic stenosis in children.

The Journal of laryngology and otology·2017
Same author

[Extended coronary dissection caused by severe polytrauma with contusio cordis : Venoarterial ECMO-assisted percutaneous coronary intervention].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2015
Same author

Employment after liver transplantation: a review.

Transplantation proceedings·2015
Same author

Nasal dermoids in children: a proposal for a new classification based on 103 cases at Great Ormond Street Hospital.

International journal of pediatric otorhinolaryngology·2014

Hepatitis C virus (HCV) genotype 1 patients respond differently to interferon therapy. Nonresponders with genotype 1 showed slower HCV RNA decrease compared to genotypes 2 and 3.

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Hepatitis C virus (HCV) infection is a global health concern.
  • Interferon-based therapies have been used to treat chronic hepatitis C.
  • Lower response rates are observed in patients with HCV genotype 1.

Purpose of the Study:

  • To investigate the pattern of HCV RNA decline during interferon treatment across different HCV genotypes.
  • To determine if slower HCV clearance contributes to lower response rates in genotype 1 patients.
  • To compare the efficacy of consensus interferon (CIFN) and interferon alfa-2b (IFN alfa-2b) in relation to HCV genotype.

Main Methods:

  • Analysis of serum HCV RNA levels in 472 chronic hepatitis C patients.
  • Patients were treated with either CIFN or IFN alfa-2b.

Related Experiment Videos

  • Evaluation of HCV RNA decline patterns based on genotype and treatment response (sustained responders, relapsers, nonresponders).

    • Main Results:

    • Sustained responders and relapsers showed similar HCV RNA decline patterns regardless of genotype.
    • Nonresponders with genotype 1 exhibited a significantly slower HCV RNA decrease compared to genotypes 2 and 3.
    • HCV genotype 1 patients receiving CIFN showed a greater HCV RNA decrease than those receiving IFN alfa-2b, but no difference was observed for genotypes 2 or 3.

    Conclusions:

    • HCV genotype and treatment outcome significantly influence the rate of HCV RNA decline during interferon therapy.
    • Genotype 1 nonresponders demonstrate impaired viral kinetics compared to other genotypes.
    • Consensus interferon may offer a more pronounced viral load reduction in genotype 1 patients.